Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA: phase III studies - Michaeli, Daniel; Mills, Mackenzie; Michaeli, Christoph T.; Miracolo, Aurelio; Kanavos, Panos (Investigational new drugs, 2022)
Gesehen am 24.10.2023